Introduction Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with limited treatment options. Due to its invasive nature, current therapies fail to provide long-term survival benefits, leaving the glioblastoma multiforme survival rate distressingly low. Most patients face a median survival of just over a year post-diagnosis. However, the glioblastoma market by...

  The Orthobiologics Market is revolutionizing musculoskeletal treatment by offering regenerative solutions that harness the body's natural healing abilities. These therapies, including stem cells, platelet-rich plasma (PRP), and bone graft substitutes, are reducing reliance on traditional surgeries. As demand for minimally invasive and highly effective treatments grows, orthobiologics are...